Partnership Opportunities in Drug Delivery (PODD) 2018
In-Person Event
Oct 17 - 18, 2018
Boston, Massachusetts, USASpeakers
OVERVIEW
8th Annual Partnership Opportunities in Drug Delivery (PODD) is organized by The Conference Forum (TCF) and will be held from Oct 17 - 18, 2018 at The Westin Copley Place, Boston, Boston, Massachusetts, United States of America.
Who Should Attend:
• Business Development
• External Licensing/Development
• Technology Licensing
• Portfolio Management
• Research & Technology Development
• Formulation Sciences/Development
• Dosage Formulation Development
• Novel Delivery Systems
• Head of CMC
From Drug Delivery and Specialty Pharma:
• Business Development
• Licensing
• Marketing
• Formulation Sciences
• Technology Development
• Commercial Development
Course Description:
The drug delivery industry is expected to experience robust growth over the next five to ten years, primarily due to the increasing prevalence of chronic conditions and the growing geriatric population. Often, the most complex part of developing a therapeutic is to design an appropriate delivery system for it. The use of drug delivery technologies will continue to rise, as the industry focuses on more cost-effective, targeted, and patient-centered therapies.
Key benefits in 2018 include:
• Hear from renowned biomedical engineer and entrepreneur, Dr Robert Langer and highly accomplished investor and biotech executive, Amy Schulman, as they address collaboration in drug delivery and what it takes to bring game-changing technologies and therapeutics to the market.
• Learn about the latest drug delivery technology solutions for both small and large molecule drugs, ranging from oral, transdermal, and transmucosal dosage forms to more patient-friendly delivery devices (more than 45 presentations and 50 exhibitors).
• Network with key decision makers from pharmaceutical, biotechnology, and medical device companies and explore areas for potential collaboration (more than 8 hours of networking).
• Discover the current drug delivery needs of pharma and biotech companies and determine what they are looking for in terms of external delivery technologies.
• Understand the potential impact digital health applications and digitally-enabled drug delivery systems can have on improving patient adherence and overall health outcomes.
The PODD promise:
• To present a strategic-level program for pharma and biotech scientists and business development professionals, with a thorough overview on formulation needs, the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
• To provide drug delivery and specialty pharmas with a platform to present their technologies.
• To offer ample networking time and services for one-on-one meetings to establish new business contacts and enhance existing ones.
2018 Featured Keynotes already confirmed include:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
Amy Schulman, Co-founder and CEO, Lyndra and Partner at Polaris
Jeffrey Karp, PhD, Associate Professor of Medicine, Harvard Medical School
Justin Wright, PhD, Global Head of Innovation, Novartis
Time: 8:00 am - 5:00 pm
Speakers: Jeffrey Karp, PhD, Robert Langer, PhD, Amy Schulman, Justin M Wright, PhD, Nima Akhavein, PhD, Orn Almarsson, PhD, Cindy Atwell, Advait Badkar, PhD, Nancy Barbour, Ulrich Bruggemann, Danile Casimiro, PhD, Bharatt Chowrira, PhD, JD, Christopher Coletta, Michael Cucolo, Mark Currie, PhD, Ann L Daugherty, PhD, Marian Gindy, PhD, Lubomir Gradinarsky, PhD, Kristen C Kozofsky, Patrick Lim Soo, PhD, Barbara Lueckel, PhD, Dhairya Mehta, Margaret Reiff, Kal Patel, MD, Joel Richard, PhD, Mathias Romacker, Manuel Sanchez-Felix, PhD, Kurt R Sedo, Srini Sridharan, PhD, Rosemarie Truman, Neil Williams, Sybil Williams, PhD
Additional details will be posted as soon as they are available.
Who Should Attend:
• Business Development
• External Licensing/Development
• Technology Licensing
• Portfolio Management
• Research & Technology Development
• Formulation Sciences/Development
• Dosage Formulation Development
• Novel Delivery Systems
• Head of CMC
From Drug Delivery and Specialty Pharma:
• Business Development
• Licensing
• Marketing
• Formulation Sciences
• Technology Development
• Commercial Development
Course Description:
The drug delivery industry is expected to experience robust growth over the next five to ten years, primarily due to the increasing prevalence of chronic conditions and the growing geriatric population. Often, the most complex part of developing a therapeutic is to design an appropriate delivery system for it. The use of drug delivery technologies will continue to rise, as the industry focuses on more cost-effective, targeted, and patient-centered therapies.
Key benefits in 2018 include:
• Hear from renowned biomedical engineer and entrepreneur, Dr Robert Langer and highly accomplished investor and biotech executive, Amy Schulman, as they address collaboration in drug delivery and what it takes to bring game-changing technologies and therapeutics to the market.
• Learn about the latest drug delivery technology solutions for both small and large molecule drugs, ranging from oral, transdermal, and transmucosal dosage forms to more patient-friendly delivery devices (more than 45 presentations and 50 exhibitors).
• Network with key decision makers from pharmaceutical, biotechnology, and medical device companies and explore areas for potential collaboration (more than 8 hours of networking).
• Discover the current drug delivery needs of pharma and biotech companies and determine what they are looking for in terms of external delivery technologies.
• Understand the potential impact digital health applications and digitally-enabled drug delivery systems can have on improving patient adherence and overall health outcomes.
The PODD promise:
• To present a strategic-level program for pharma and biotech scientists and business development professionals, with a thorough overview on formulation needs, the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
• To provide drug delivery and specialty pharmas with a platform to present their technologies.
• To offer ample networking time and services for one-on-one meetings to establish new business contacts and enhance existing ones.
2018 Featured Keynotes already confirmed include:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
Amy Schulman, Co-founder and CEO, Lyndra and Partner at Polaris
Jeffrey Karp, PhD, Associate Professor of Medicine, Harvard Medical School
Justin Wright, PhD, Global Head of Innovation, Novartis
Time: 8:00 am - 5:00 pm
Speakers: Jeffrey Karp, PhD, Robert Langer, PhD, Amy Schulman, Justin M Wright, PhD, Nima Akhavein, PhD, Orn Almarsson, PhD, Cindy Atwell, Advait Badkar, PhD, Nancy Barbour, Ulrich Bruggemann, Danile Casimiro, PhD, Bharatt Chowrira, PhD, JD, Christopher Coletta, Michael Cucolo, Mark Currie, PhD, Ann L Daugherty, PhD, Marian Gindy, PhD, Lubomir Gradinarsky, PhD, Kristen C Kozofsky, Patrick Lim Soo, PhD, Barbara Lueckel, PhD, Dhairya Mehta, Margaret Reiff, Kal Patel, MD, Joel Richard, PhD, Mathias Romacker, Manuel Sanchez-Felix, PhD, Kurt R Sedo, Srini Sridharan, PhD, Rosemarie Truman, Neil Williams, Sybil Williams, PhD
Additional details will be posted as soon as they are available.
KEY DATES
17 Oct, 2018
Event Start Date
18 Oct, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
The Westin Copley Place, BostonRELATED CONFERENCES & LIVE WEBINARS
Quick Links